Abstract:The progress in the development of various vaccine platforms against SARS-CoV-2 have been rather remarkable owing to advancement in molecular and biologic sciences. Most of the current vaccines and those in development focus on targeting the viral spike proteins by generating antibodies of varying spectrum. These vaccines represent a variety of platforms including whole virus vaccines, viral vector vaccines, nucleic acid vaccines representing RNA, DNA, and their hybrid forms.The therapeutic efficacy of these vaccines varies owing to their pharmacodynamic individualities. COVID-19 variants are capable of inducing different pathologic responses and some of which may be resistant to antibodies generated by current vaccines. The current clinical use of these vaccines has been through emergency use authorization until recently. Moreover, the efficacy and safety of these vaccines have been tested in substantial numbers of individuals but studies in special populations that better reflect the global population are pending results. These specialized populations include young children, immunocompromised patients, pregnant individuals, and other specialized groups. Combination approaches, molecularly modified vaccination approaches, and vaccines conferring longer periods of immunity are being currently being investigated, as well as pharmacovigilance studies.The continual transformation of SARS-CoV-2 and its variants are of concern along with the breakthrough infections. These considerations pose new challenges for the development of vaccination platforms. For this purpose, booster doses, combination vaccine approaches, and other modalities are being discussed. This review provides an updated account of currently available vaccines and those in advanced development with reference to their composition and mechanisms of action.A discussion on the use of vaccines in special populations including immunocompromised patients, pregnant women and other specialized populations are also included.

SARS-CoV-2 Vaccine Development: Current Status

Status Report on COVID-19 Vaccines Development

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects

SARS-CoV-2 vaccine candidates in rapid development

Development of SARS-CoV-2 vaccines

SARS-CoV-2 Vaccine Development and Challenges

COVID-19: Coronavirus Vaccine Development Updates

An overview of vaccine development for COVID-19

SARS-CoV-2 vaccines in development

COVID-19 vaccine: where are we now and where should we go?

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies

Application of Traditional Vaccine Development Strategies to SARS-CoV-2

Coronavirus vaccine development: from SARS and MERS to COVID-19

SARS-CoV-2 Vaccines: Status Report

SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus

The way of SARS-CoV-2 vaccine development: success and challenges

Efforts at COVID-19 Vaccine Development: Challenges and Successes

SARS-CoV-2: vaccines in the pandemic era

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations